FDA approves gene therapy for cancer, GLP-1 fallout and a new 340B reform push.
July 22, 2026

1. FDA approves gene-targeting cancer drug Full story

2. The hidden cost of the GLP-1 boom: 5 notes Full story

3. How CFOs at UMMS, County of Santa Clara Health System are building long-term financial resilience: here.

 

4. New cholesterol guideline adds 21.5M statin candidates: 4 study notes Full story

5. GLP-1 compounders find loophole in FDA crackdown, study suggests Full story

6. Interoperability + agentic AI are converging. Hear what that means for clinical operations here.

 

7. Brand-name drug denials surge: JAMA Full story

8. Lawmaker proposes sweeping 340B reforms Full story

Becker’s Learning Opportunities

9. Supply chain is no longer just sourcing — see what leading health systems are doing differently here.

10. Clinical teams spend 40% of time chasing charts. A cleaner records path here.

11. Which recruiting channels are still delivering qualified healthcare candidates and which to cut here.

12. Becker’s resources don’t stop here — explore more webinars and whitepapers.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 
 

 

Contact Us, Feedback, or Questions – Email ldyrda@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker’s Hospital Review, A Becker’s Healthcare Publication